The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice

Kiyoyuki Kitaichi, Yousuke Minami, Manabu Amano, Kiyofumi Yamada, Takaaki Hasegawa, Toshitaka Nabeshima

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We investigated whether triazolam attenuated the suppression of motility in the conditioned fear stress task in mice and whether ethanol modified the effects of triazolam. When mice were placed 24 hours later (retention test) in the same environment in which they had previously been exposed to an electric foot shock (training), they exhibited a marked suppression of motility (conditioned fear stress). Triazolam (0.01-0.1 mg/Kg, S.c.), administered before training, attenuated the suppression of motility in the conditioned fear stress task in a dose-dependent manner, without affecting the sensitivity to an electric foot shock. The doses of triazolam that attenuated the suppression of motility were much lower that those of chlordiazepoxide (5-10 mg/Kg, S.c.). Neither drug, administered before the retention test, attenuated the suppression of motility in the conditioned fear stress task. These results suggest that both benzodiazepines may inhibit the process of acquisition, but not the process of recall, of memory. Ethanol (1 g/Kg, P.o.), which, by itself, did not affect either the suppression of motility or the sensitivity to an electric fool shock, exacerbated the attenuation of the suppression of motility in the conditioned fear stress task induced by both triazolam (0.01 mg/kg) and chlordiazepoxide (5 mg/kg). These results suggest that ethanol exacerbates the effects of benzodiazepines.

Original languageEnglish
Pages (from-to)743-753
Number of pages11
JournalLife Sciences
Volume57
Issue number8
DOIs
Publication statusPublished - 14-07-1995
Externally publishedYes

Fingerprint

Triazolam
Fear
Ethanol
Chlordiazepoxide
Shock
Benzodiazepines
Foot
Data storage equipment
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kitaichi, Kiyoyuki ; Minami, Yousuke ; Amano, Manabu ; Yamada, Kiyofumi ; Hasegawa, Takaaki ; Nabeshima, Toshitaka. / The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice. In: Life Sciences. 1995 ; Vol. 57, No. 8. pp. 743-753.
@article{97d6957c2c0045d6b8980b37443f4250,
title = "The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice",
abstract = "We investigated whether triazolam attenuated the suppression of motility in the conditioned fear stress task in mice and whether ethanol modified the effects of triazolam. When mice were placed 24 hours later (retention test) in the same environment in which they had previously been exposed to an electric foot shock (training), they exhibited a marked suppression of motility (conditioned fear stress). Triazolam (0.01-0.1 mg/Kg, S.c.), administered before training, attenuated the suppression of motility in the conditioned fear stress task in a dose-dependent manner, without affecting the sensitivity to an electric foot shock. The doses of triazolam that attenuated the suppression of motility were much lower that those of chlordiazepoxide (5-10 mg/Kg, S.c.). Neither drug, administered before the retention test, attenuated the suppression of motility in the conditioned fear stress task. These results suggest that both benzodiazepines may inhibit the process of acquisition, but not the process of recall, of memory. Ethanol (1 g/Kg, P.o.), which, by itself, did not affect either the suppression of motility or the sensitivity to an electric fool shock, exacerbated the attenuation of the suppression of motility in the conditioned fear stress task induced by both triazolam (0.01 mg/kg) and chlordiazepoxide (5 mg/kg). These results suggest that ethanol exacerbates the effects of benzodiazepines.",
author = "Kiyoyuki Kitaichi and Yousuke Minami and Manabu Amano and Kiyofumi Yamada and Takaaki Hasegawa and Toshitaka Nabeshima",
year = "1995",
month = "7",
day = "14",
doi = "10.1016/0024-3205(95)02001-Y",
language = "English",
volume = "57",
pages = "743--753",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "8",

}

The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice. / Kitaichi, Kiyoyuki; Minami, Yousuke; Amano, Manabu; Yamada, Kiyofumi; Hasegawa, Takaaki; Nabeshima, Toshitaka.

In: Life Sciences, Vol. 57, No. 8, 14.07.1995, p. 743-753.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice

AU - Kitaichi, Kiyoyuki

AU - Minami, Yousuke

AU - Amano, Manabu

AU - Yamada, Kiyofumi

AU - Hasegawa, Takaaki

AU - Nabeshima, Toshitaka

PY - 1995/7/14

Y1 - 1995/7/14

N2 - We investigated whether triazolam attenuated the suppression of motility in the conditioned fear stress task in mice and whether ethanol modified the effects of triazolam. When mice were placed 24 hours later (retention test) in the same environment in which they had previously been exposed to an electric foot shock (training), they exhibited a marked suppression of motility (conditioned fear stress). Triazolam (0.01-0.1 mg/Kg, S.c.), administered before training, attenuated the suppression of motility in the conditioned fear stress task in a dose-dependent manner, without affecting the sensitivity to an electric foot shock. The doses of triazolam that attenuated the suppression of motility were much lower that those of chlordiazepoxide (5-10 mg/Kg, S.c.). Neither drug, administered before the retention test, attenuated the suppression of motility in the conditioned fear stress task. These results suggest that both benzodiazepines may inhibit the process of acquisition, but not the process of recall, of memory. Ethanol (1 g/Kg, P.o.), which, by itself, did not affect either the suppression of motility or the sensitivity to an electric fool shock, exacerbated the attenuation of the suppression of motility in the conditioned fear stress task induced by both triazolam (0.01 mg/kg) and chlordiazepoxide (5 mg/kg). These results suggest that ethanol exacerbates the effects of benzodiazepines.

AB - We investigated whether triazolam attenuated the suppression of motility in the conditioned fear stress task in mice and whether ethanol modified the effects of triazolam. When mice were placed 24 hours later (retention test) in the same environment in which they had previously been exposed to an electric foot shock (training), they exhibited a marked suppression of motility (conditioned fear stress). Triazolam (0.01-0.1 mg/Kg, S.c.), administered before training, attenuated the suppression of motility in the conditioned fear stress task in a dose-dependent manner, without affecting the sensitivity to an electric foot shock. The doses of triazolam that attenuated the suppression of motility were much lower that those of chlordiazepoxide (5-10 mg/Kg, S.c.). Neither drug, administered before the retention test, attenuated the suppression of motility in the conditioned fear stress task. These results suggest that both benzodiazepines may inhibit the process of acquisition, but not the process of recall, of memory. Ethanol (1 g/Kg, P.o.), which, by itself, did not affect either the suppression of motility or the sensitivity to an electric fool shock, exacerbated the attenuation of the suppression of motility in the conditioned fear stress task induced by both triazolam (0.01 mg/kg) and chlordiazepoxide (5 mg/kg). These results suggest that ethanol exacerbates the effects of benzodiazepines.

UR - http://www.scopus.com/inward/record.url?scp=0029164682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029164682&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(95)02001-Y

DO - 10.1016/0024-3205(95)02001-Y

M3 - Article

C2 - 7637548

AN - SCOPUS:0029164682

VL - 57

SP - 743

EP - 753

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 8

ER -